Oryzon Genomics S.A. (BME:ORY)
Spain · Delayed Price · Currency is EUR 2.820
-0.020 (-0.70%)
Aug 27, 2026, 5:35 PM CET
Oryzon Genomics Market Cap
Oryzon Genomics has a market cap or net worth of €232.77 million as of August 27, 2026. Its market cap has increased by 8.02% in one year.
Market Cap
232.77M
Enterprise Value
228.88M
Revenue
15.41M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.82
ChartMarket Cap Chart
Since December 14, 2015, Oryzon Genomics's market cap has increased from 122.00M to 232.77M, an increase of 90.80%. That is a compound annual growth rate of 6.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 232.77M | -5.08% |
| Dec 31, 2025 | 245.23M | 170.69% |
| Dec 31, 2024 | 90.60M | -16.71% |
| Dec 29, 2023 | 108.78M | -18.27% |
| Dec 30, 2022 | 133.08M | -6.58% |
| Dec 30, 2021 | 142.46M | -32.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.97B |
| Laboratorios Farmaceuticos Rovi | 3.06B |
| Almirall | 2.28B |
| Pharma Mar | 1.44B |
| Clínica Baviera | 942.75M |
| Prim, S.A. | 226.21M |
| Laboratorio Reig Jofre | 219.00M |
| Atrys Health | 192.04M |